DANIELLE JOSLIN: Open Payments
NPI 1386171213 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 44 payments from 12 companies in 2025. Trend: 2023 $650 · 2024 $817 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $173 |
| Novo Nordisk Inc | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| PFIZER INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $41 |
| Philips North America LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
Products named: Kerendia, Ozempic, NURTEC ODT, AIRSUPRA, CAPLYTA, FARXIGA, REXULTI, Auvelity.
Industry payments across TN — which companies pay providers there.
